Skip to main content
JUSH
OTC Life Sciences

CEO Cacioppo's Group Discloses 19.9% Stake After $1M Open-Market Buying Spree

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Positive
Importance info
7
Price
$0.595
Mkt Cap
$118.82M
52W Low
$0.34
52W High
$0.95
52W Position info
75% above low
Off High info
37% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

JUSH sits 75% above its 52-week low of $0.34 on elevated volume (1.9× avg).

Summary

CEO James Cacioppo's investment group now holds 19.9% of Jushi Holdings after buying 2.02 million shares for $1.01 million in open-market purchases over eight days.


Key Events · Ownership and Investor Activity · JUSH

  • CEO Group Hits 19.9% Ownership Cap

    James Cacioppo and affiliated entities now beneficially own 45,661,447 shares (19.9% of class), the maximum permitted under blocker provisions in his warrants and options.

  • $1.01M Open-Market Buying Spree

    One East Partners L.P. purchased 2,019,798 shares for $1,010,011 between August 24 and September 1, 2026, at prices ranging from $0.4768 to $0.5275 per share.

  • Nevada Continuance Completed

    On July 30, 2026, Jushi completed its continuance from British Columbia to Nevada, converting all Subordinate Voting Shares to Common Stock on a 1:1 basis.

  • Warrant and Option Overhang

    The group holds 6,000,000 options and 22,723,184 warrants exercisable within 60 days, representing significant potential future share issuance.


Analysis · JUSH · Life Sciences

This 13D/A reveals that CEO James Cacioppo and his affiliated entities now control 45.7 million shares — 19.9% of Jushi Holdings — after One East Partners L.P. bought 2.02 million shares for $1.01 million between August 24 and September 1. The purchases were made at $0.48–$0.53 per share, consistent with the CEO's three separate Form 4 filings over the past week. The 19.9% ownership level is the maximum allowed under blocker provisions in his warrants and options, meaning Cacioppo has effectively maxed out his permitted beneficial ownership. This concentrated insider accumulation at prices near the stock's lows is a strong conviction signal from the company's top executive.

How filings like this one have moved

In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JUSH was trading at $0.60 on OTC in the Life Sciences sector, with a market capitalization of approximately $118.8M. The 52-week trading range was $0.34 to $0.95. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JUSH - Latest Insights

JUSH
Sep 02, 2026, 4:10 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.560
Real-time Price: $0.595 info
Change: +$0.035 (+6%) info
Market Cap: $118.82M info
JUSH
Aug 28, 2026, 4:07 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.5104
Real-time Price: $0.595 info
Change: +$0.0846 (+17%) info
Market Cap: $118.82M info
JUSH
Aug 26, 2026, 4:06 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.5067
Real-time Price: $0.595 info
Change: +$0.0883 (+17%) info
Market Cap: $118.82M info